MDXG MiMedx
- 7.370
- -0.130-1.73%
- 7.160
- -0.210-2.85%
MiMedx News
Buy Rating Affirmed for MiMedx on Strong Performance and Favorable Market Outlook
HC Wainwright & Co. : The MiMedx Group (MDXG.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $11.00.
MiMedx Group Analyst Ratings
HC Wainwright & Co. Reiterates Buy on MiMedx Group, Maintains $11 Price Target
MiMedx Group: Strong Financial Performance and Future Growth Potential Affirm Buy Rating
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), MiMedx Group (MDXG) and Petmed Express (PETS)
Analysts Are Bullish on These Healthcare Stocks: Cerus (CERS), MiMedx Group (MDXG)
MiMedx Group (MDXG) Receives a Buy From Northland Securities
Analysts Conflicted on These Healthcare Names: Cellectar Biosciences (CLRB), MiMedx Group (MDXG) and Marinus (MRNS)
Northland Securities Keeps Their Buy Rating on MiMedx Group (MDXG)
Analysts Conflicted on These Healthcare Names: Diamedica Therapeutics (DMAC), Design Therapeutics (DSGN) and MiMedx Group (MDXG)
MiMedx Group Analyst Ratings
Mizuho Maintains Buy on MiMedx Group, Raises Price Target to $14
MiMedx Group Analyst Ratings
MiMedx Group: Strong Q4 Performance and Promising Growth Prospects Justify Buy Rating
MiMedx Group (MDXG) Receives a Buy From Craig-Hallum
Analysts Are Bullish on Top Healthcare Stocks: Zoetis (ZTS), MiMedx Group (MDXG)
Northland Securities Sticks to Its Buy Rating for MiMedx Group (MDXG)
Northland Securities Sticks to Their Buy Rating for MiMedx Group (MDXG)
Analysts Offer Insights on Healthcare Companies: Streamline Health Solutions (STRM), MiMedx Group (MDXG) and Integra Lifesciences (IART)
Analysis
Price Target
No Data
